Global ATP assays Market - 2022-2029

Global ATP assays Market - 2022-2029
Market Overview

ATP Assays Market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of YY % during the forecast period (2022-2029).

ATP or Adenosine triphosphate is an organic substance that is the main energy source in all living things and powers various biological functions like nerve impulse transmission, muscular contraction, and chemical synthesis. Since the presence of ATP influences a cell's viability, the concentration of ATP directly correlates with the number of active cells. Cell viability is measured, and bacteria and other microbes are found using ATP assays, which are ATP detection techniques. The fluorescent, bioluminescent, and colorimetric ATP tests are the most widely used ATP assays. Due to its better practicality, increased sensitivity, homogeneous technique, and quick results, bioluminescent ATP assays are the most optimal. These tests are widespread in diagnostic labs, hospitals, and research labs. They are also widely used in the food and beverage industry to determine the cleanliness and safety of food or liquid samples. As they are better at identifying the overall microbial content of samples, ATP assays are now increasingly favored over traditional culture-based diagnostics. A few benefits of ATP tests include quick testing and monitoring, increased sensitivity, and quicker, more precise results.

Market Dynamics

The rising adoption of Rapid ATP bioluminescence assays in various industries is expected to drive in the forecast period.

Rapid ATP bioluminescence tests are widely used across many end-use industries, including the pharmaceutical, biotechnology, healthcare, and food & beverage industries. These tests accurately determine the number of microorganisms in food and medicine samples and evaluate the amount of dirt or contaminants on different surfaces. Moreover, the demand for quick ATP bioluminescence assays has been driven by the rising rate of hospital-acquired infections, increasing adoption of advanced sanitization techniques, increasing public health & hygiene initiatives, and growing use of ATP assays in water and wastewater treatment plants to detect microbial contamination. Thus, from the above statements, the market is expected to drive in the forecast period.

Restraint:

The high cost of the instruments, the inability to differentiate between extracellular and intracellular ATP are some of the factors the market is expected to get hampered in the forecast period.

Industry Analysis

The ATP assays market provides in-depth analysis of the market based on various industry factors such as porter five forces, supply chain, pricing analysis etc.

COVID-19 Impact Analysis

The COVID-19 pandemic has positively impacted the market. Cell culture media use for COVID-19 research has increased due to the manufacturing of vaccines during pandemics. Pharmaceutical and biotechnology firms, research institutes, and university institutions conduct critical vaccine-related research with largely unaffected operations and output. For COVID-19, several vaccines or antiviral medications have already received approval or are being created. This has raised the demand for cell assay products like ATP assays used in pharmaceutical firms and medical settings to decontaminate surfaces and equipment. Moreover, the increased demand for cell-based assays in developing pharmaceuticals and vaccines, the number of approved medications and biologics, overall clinical trials, and the expanding biologics market with the growth in pharma R&D spending all point to an expected increase in the usage of ATP assays. Thus, from the above statements, the market is expected to boost the forecast period.

Segment Analysis

Consumables & Accessories segment is expected to hold the largest market share in ATP assays market.

The consumables & accessories segment accounted for the largest market share in 2021. The segment is sub-segmented into reagents & kits, microplates, and other consumables & accessories. Moreover, the segment is benefited from the widespread use of ATP assays in research facilities to assess cell viability, the rise in drug discovery brought on by the prevalence of chronic diseases that necessitate tumor testing and cell proliferation (in cancer), and the regular expenditure of funds by pharmaceutical and biotechnology firms on consumables. Therefore, it has increased the adoption of the ATP assays consumables & accessories.

Geographical Analysis

North America region holds the largest market share in the global ATP assays market

In 2021, the North American ATP assays accounted for the highest revenue share in the global market. The increasing prevalence of chronic diseases like cancer, rising cases of coronavirus in the region, presence of large pharmaceutical & biotechnology industries, rising demand for cell-based assays in research and rising funding for drug development by the marker players are the factors the market is expected to boost in the forecast period. For instance, according to the American Cancer Society, In 2020, an estimated 1.8 million new cancer cases and 606,520 cancer deaths in the United States will be diagnosed. In contrast, in 2021, an estimated 1.9 million new cancer cases will be diagnosed and 608,570 cancer deaths in the United States. Moreover, With a combined expenditure of USD 44.2 million (EUR 40 million) at its manufacturing plants in Danvers, Massachusetts, and Jaffrey, New Hampshire, Merck expanded its manufacturing footprint in 2020. These websites offer vital products to clients creating life-saving medications, such as COVID-19 vaccinations, as well as goods and services for the production of biopharmaceuticals. Therefore, it has increased the demand for the ATP assays, and thus the North American region accounted for the largest market share.

Competitive Landscape

Major key players in the ATP assays market are Thermo Fisher Scientific, Inc., Promega Corporation, Merck KGaA, PerkinElmer, Inc., Agilent Technologies, Inc., Abcam plc, Lonza Group, 3M, Xylem, Geno Technology Inc.

Thermo Fisher Scientific, Inc.:

Overview:

Thermo Fisher Scientific is an American company incorporated in 1956 and based in Waltham, Massachusetts. The company offers worldwide life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and services. Moreover, the global team has more than 90,000 colleagues who deliver an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon.

Product Portfolio:

Invitrogen ATP Determination Kit: Molecular Probes ATP Determination Kit offers a convenient bioluminescence assay for quantitatively determining ATP with recombinant firefly luciferase and its substrate D-luciferin. This sensitivity has led to numerous applications for detecting ATP production in various enzymatic reactions, including ATPase and NADPH oxidase, as well as for detecting low-level bacterial contamination in samples such as blood, milk, urine, soil and sludge. The luciferin–luciferase bioluminescence assay has also been used successfully to study the effects of antibiotics on bacterial populations, to determine cell proliferation and cytotoxicity in both bacterial and mammalian cells, and to distinguish cytostatic versus the cytocidal potential of anticancer drugs on malignant cell growth.

The global ATP assays market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.